Cargando…
Nebulized levofloxacin for chronic Burkholderia cenocepacia pulmonary infection in cystic fibrosis: A case report
We present a patient with cystic fibrosis who used nebulized levofloxacin off-label to suppress chronic Burkholderia cenocepacia pulmonary infection. The patient was initially using tobramycin inhalation powder (TIP) off-label continuously for suppression of chronic B. cenocepacia; this was changed...
Autores principales: | Dagenais, Renée VE., Quon, Bradley S., Franciosi, Alessandro N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674917/ https://www.ncbi.nlm.nih.gov/pubmed/36411822 http://dx.doi.org/10.1016/j.rmcr.2022.101772 |
Ejemplares similares
-
Genetic similarity of Burkholderia cenocepacia from cystic fibrosis patients
por: Pretto, Luana, et al.
Publicado: (2013) -
What matters in chronic Burkholderia cenocepacia infection in cystic fibrosis: Insights from comparative genomics
por: Nunvar, Jaroslav, et al.
Publicado: (2017) -
Burkholderia cenocepacia Infections in Cystic Fibrosis Patients: Drug Resistance and Therapeutic Approaches
por: Scoffone, Viola C., et al.
Publicado: (2017) -
A novel method for investigating Burkholderia cenocepacia infections in patients with cystic fibrosis and other chronic diseases of the airways
por: Wijers, Christiaan D. M., et al.
Publicado: (2016) -
Phenotypic diversity and genotypic flexibility of Burkholderia cenocepacia during long-term chronic infection of cystic fibrosis lungs
por: Lee, Amy Huei-Yi, et al.
Publicado: (2017)